Oxidative stress is associated with C-reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance

Clinical Endocrinology

Volumn 79, Issue 1, 2013, Pages 65-70

  Park, Seonmin ^a   Kim, Minjoo ^a   Paik, Jean Kyung ^b   Jang, Yoon Jung ^a   Lee, Sang Hyun ^c   Lee, Jong Ho ^a  

^a Yonsei University   (South Korea)

^b Eulji University   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROSTAGLANDIN F2 ALPHA;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DRINKING; FEMALE; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; OBESITY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; DINOPROST; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LIPOPROTEINS, LDL; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; POSTMENOPAUSE; RISK FACTORS;

EID: 84878585405     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04512.x     Document Type: Article

References (35)

1. Hopps, E., Noto, D., Caimi, G., et al,. (2010) A novel component of the metabolic syndrome: the oxidative stress. Nutrition, Metabolism, and Cardiovascular Disease, 20, 72-77.
2. Hotamisligil, G.S., (2006) Inflammation and metabolic disorders. Nature, 444, 860-867.
3. Roberts, C.K., &, Sindhu, K.K., (2009) Oxidative stress and metabolic syndrome. Life Sciences, 84, 705-712.
4. Federico, A., Morgillo, F., Tuccillo, C., et al,. (2007) Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer, 121, 2381-2386.
5. Furukawa, S., Fujita, K., Shimabukuro, M., et al,. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation, 114, 1752-1761.
6. Meigs, J.B., Larson, M.G., Fox, C.S., et al,. (2007) Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham offspring study. Diabetes Care, 30, 2529-2535.
7. Ceriello, A., &, Motz, E., (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 816-823.
8. Hulthe, J., Wikstrand, J., &, Fagerberg, B., (2001) Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clinical Science (London), 100, 371-378.
9. Yudkin, J.S., Kumari, M., Humphries, S.E., et al,. (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis, 148, 209-214.
10. Barinas-Mitchell, E., Cushman, M., Meilahn, E.N., et al,. (2001) Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. American Journal of Epidemiology, 153, 1094-1101.
11. Kundu, J.K., &, Surh, Y.J., (2012) Emerging avenues linking inflammation and cancer. Free Radical Biology and Medicine, 52, 2013-2037.
12. Greendale, G.A., Lee, N.P., &, Arriola, E.R., (1999) The menopause. Lancet, 353, 571-580.
13. Sánchez-Rodríguez, M.A., Zacarías-Flores, M., Arronte-Rosales, A., et al,. (2012) Menopause as risk factor for oxidative stress. Menopause, 19, 361-367.
14. Roest, M., Voorbij, H.A., Van der Schouw, Y.T., et al,. (2008) High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women. Journal of Clinical Lipidology, 2, 298-303.
15. Chou, H.-H., Hsu, L.-A., Liu, C.-J., et al,. (2010) Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. Metabolism, 59, 824-830.
16. Niehoff, A.G., van Haeften, T.W., Onland-Moret, N.C., et al,. (2007) C-reactive protein is independently associated with glucose but not with insulin resistance in healthy men. Diabetes Care, 30, 1627-1629.
17. Xu, Y., Zhao, Z., Li, X., et al,. (2011) Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population. Endocrine, 39, 175-181.
18. Basu, S., (2004) Isoprostanes: novel bioactive products of lipid peroxidation. Free Radical Research, 38, 105-122.
19. Roberts, L.J. 2nd, &, Morrow, J.D., (2002) Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation. Cellular and Molecular Life Sciences, 59, 808-820.
20. Kim, J.Y., Hyun, Y.J., Jang, Y., et al,. (2008) Lipoprotein-associated phospholipase A2 activity is associated with coronary artery disease and markers of oxidative stress: a case-control study. American Journal of Clinical Nutrition, 88, 630-637.
21. Richelle, M., Turini, M.E., Guidoux, R., et al,. (1999) Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Letters, 459, 259-262.
22. Gopaul, N.K., Halliwell, B., &, Anggard, E.E., (2000) Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Radical Research, 33, 115-127.
23. Kanabrocki, E.L., Murray, D., Hermida, R.C., et al,. (2002) Circadian variation in oxidative stress markers in healthy and type II diabetic men. Chronobiology International, 19, 423-439.
24. Morrow, J.D., &, Roberts, L.J., (2002) The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 166, 25S-30.
25. Sjogren, P., Basu, S., Rosell, M., et al,. (2005) Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2580-2586.
26. Couillard, C., Ruel, G., Archer, W.R., et al,. (2005) Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. Journal of Clinical Endocrinology and Metabolism, 90, 6454-6459.
27. Il'yasova, D., Ivanova, A., Morrow, J.D., et al,. (2008) Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers, 13, 41-51.
28. Schwedhelm, E., Bartling, A., Lenzen, H., et al,. (2004) Urinary 8-iso-prostablandin F2α as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation, 109, 843-848.
29. Roberts, L.J., &, Morrow, J.D., (2000) Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine, 28, 505-513.
30. Proudfoot, J.M., Barden, A.E., Loke, W.M., et al,. (2009) HDL is the major lipoprotein carrier of plasma F2-isoprostanes. Journal of Lipid Research, 50, 716-722.
31. Chun, S., Min, W.K., Park, H., et al,. (1999) The risk groups for coronary heart disease in Koreans. Assessment by distribution of serum lipid concentrations. Clinical Chemistry and Laboratory Medicine, 37, 969-974.
32. Zhang, Y.C., Wei, J.J., Wang, F., et al,. (2012) Elevated levels of oxidized low-density lipoprotein correlate positively with C-reactive protein in patients with acute coronary syndrome. Cell Biochemistry and Biophysics, 62, 365-372.
33. Morteza, A., Nakhjavani, M., Ghadiri-Anari, A., et al,. (2011) Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes. European Cytokine Network, 22, 107-112.
34. Ehara, S., Ueda, M., Naruko, T., et al,. (2001) Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 103, 1955-1960.
35. Kühn, H., Heydeck, D., Hugou, I., et al,. (1997) In vivo action of 15-lipoxygenase in early stages of human atherogenesis. The Journal of Clinical Investigation, 99, 888-893.